<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34974309</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Unraveling the complex interplay between genes, environment, and climate in ALS.</ArticleTitle><Pagination><StartPage>103795</StartPage><MedlinePgn>103795</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103795</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2021.103795</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(21)00589-2</ELocationID><Abstract><AbstractText>Various genetic and environmental risk factors have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Despite this, the cause of most ALS cases remains obscure. In this review, we describe the current evidence implicating genetic and environmental factors in motor neuron degeneration. While the risk exerted by many environmental factors may appear small, their effect could be magnified by the presence of a genetic predisposition. We postulate that gene-environment interactions account for at least a portion of the unknown etiology in ALS. Climate underlies multiple environmental factors, some of which have been implied in ALS etiology, and the impact of global temperature increase on the gene-environment interactions should be carefully monitored. We describe the main concepts underlying such interactions. Although a lack of large cohorts with detailed genetic and environmental information hampers the search for gene-environment interactions, newer algorithms and machine learning approaches offer an opportunity to break this stalemate. Understanding how genetic and environmental factors interact to cause ALS may ultimately pave the way towards precision medicine becoming an integral part of ALS care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ALS Center, Department of Neuroscience "Rita Levi Montalcini", University of Turin, via Cherasco 15, Turin 1026, Italy; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging (NIH), Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging (NIH), Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traynor</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging (NIH), Bethesda, MD 20892, USA; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, University College London, London WC1N 1PJ, UK; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD 21287, USA; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA; ASO Rapid Development Laboratory, Therapeutics Development Branch, National Center for Advancing Translational Sciences, NIH, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Center, Department of Neuroscience "Rita Levi Montalcini", University of Turin, via Cherasco 15, Turin 1026, Italy; Institute of Cognitive Sciences and Technologies, C.N.R., Rome 00185, Italy; Neurology 1, AOU Citt&#xe0; della Salute e della Scienza di Torino, Turin, Italy. Electronic address: adriano.chio@unito.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z01 AG000949</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA NS003154</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044822" MajorTopicYN="N">Biodiversity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cause</Keyword><Keyword MajorTopicYN="N">Climate</Keyword><Keyword MajorTopicYN="N">Environment</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Interactions</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest Rosario Vasta and Ruth Chia declare no conflicts of interests. Bryan J. Traynor holds the US, Canadian and European patents on the clinical testing and therapeutic intervention for the hexanucleotide repeat expansion in C9orf72. He is an associate editor of Brain and sits on the editorial boards of Neurobiology of Aging, the Journal of Neurology, Neurosurgery, and Psychiatry, and EClinicalMedicine. Adriano Chi&#xf2; serves on the editorial advisory board of Amyotrophic Lateral Sclerosis and Neurological Sciences and has received research support from the Italian Ministry of Health (Ricerca Finalizzata), Regione Piemonte (Ricerca Finalizzata), University of Turin and the European Commission (Health Seventh Framework Programme) and serves on scientific advisory boards for Mitsubishi Tanabe, Roche, Denali Pharma, Cytokinetics, Biogen, and Amylyx and has a research contract with Biogen.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>2</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34974309</ArticleId><ArticleId IdType="pmc">PMC8728044</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2021.103795</ArticleId><ArticleId IdType="pii">S2352-3964(21)00589-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vasta R., Moglia C., Manera U., Canosa A., Grassano M., Palumbo F., et al. What is amyotrophic lateral sclerosis prevalence? Amyotroph Lateral Scler Frontotemporal Degener. 2021:1&#x2013;6. doi: 10.1080/21678421.2021.1936557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1936557</ArticleId><ArticleId IdType="pubmed">34151660</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Traynor B.J., Collins J., Simeone J.C., Goldstein L.A., et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Moglia C., Mazzini L., Mora G., PARALS study group Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatr. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R., Canosa A., Manera U., Di Pede F., Cabras S., De Marchi F., et al. Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2021 doi: 10.1136/jnnp-2020-325625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325625</ArticleId><ArticleId IdType="pubmed">33563811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Moglia C., Canosa A., Manera U., D'Ovidio F., Vasta R., et al. ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology. 2020;94:e802&#x2013;e810. doi: 10.1212/WNL.0000000000008869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N.M., Holmes M.V., Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi: 10.1136/bmj.k601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k601</ArticleId><ArticleId IdType="pmc">PMC6041728</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S., Noyce A.J., Traynor B.J. Mendelian randomization-A journey from obscurity to center stage with a few potholes along the way. JAMA Neurol. 2019 doi: 10.1001/jamaneurol.2019.3419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.3419</ArticleId><ArticleId IdType="pubmed">31609383</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith G.D., Ebrahim S. &#x201c;Mendelian randomization&#x201d;: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1&#x2013;22. doi: 10.1093/ije/dyg070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyg070</ArticleId><ArticleId IdType="pubmed">12689998</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian T.H., Boddy S., Islam M., Kurz J., Whittaker K.J., Moll T., et al. A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. 2021 doi: 10.1093/brain/awab420. awab420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab420</ArticleId><ArticleId IdType="pubmed">34791088</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Smoking is a cause of ALS. High LDL-cholesterol levels? Unsure. Ann Neurol. 2019 doi: 10.1002/ana.25469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25469</ArticleId><ArticleId IdType="pubmed">30883903</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham A.J., Macdonald A.M., Hawkes C.H. British motor neuron disease twin study. J Neurol Neurosurg Psychiatry. 1997;62:562&#x2013;569. doi: 10.1136/jnnp.62.6.562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.62.6.562</ArticleId><ArticleId IdType="pmc">PMC1074137</ArticleId><ArticleId IdType="pubmed">9219739</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Fang F., Hanby M.F., Leigh P.N., Shaw C.E., Ye W., et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo T.S., Cutler D.J., Yarab N., Kelly C.M., Glass J.D. The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. PLoS ONE. 2011;6:e27985. doi: 10.1371/journal.pone.0027985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027985</ArticleId><ArticleId IdType="pmc">PMC3222666</ArticleId><ArticleId IdType="pubmed">22132186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M., Heverin M., McLaughlin R.L., Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76:1367. doi: 10.1001/jamaneurol.2019.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller M.F., Ferrucci L., Singleton A.B., Tienari P.J., Laaksovirta H., Restagno G., et al. Genome-wide analysis of the heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:1123. doi: 10.1001/jamaneurol.2014.1184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1184</ArticleId><ArticleId IdType="pmc">PMC4566960</ArticleId><ArticleId IdType="pubmed">25023141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan R., Haque S., Coley K., Shepheard S., Cooper-Knock J., Kirby J. Multifaceted genes in amyotrophic lateral sclerosis-frontotemporal dementia. Front Neurosci. 2020;14:684. doi: 10.3389/fnins.2020.00684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00684</ArticleId><ArticleId IdType="pmc">PMC7358438</ArticleId><ArticleId IdType="pubmed">32733193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann M.C., Bellalta S., Basoalto R., G&#xf3;mez-Valenzuela F., Jalil Y., L&#xe9;pez M., et al. The challenge by multiple environmental and biological factors induce inflammation in aging: their role in the promotion of chronic disease. Front Immunol. 2020;11 doi: 10.3389/fimmu.2020.570083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.570083</ArticleId><ArticleId IdType="pmc">PMC7591463</ArticleId><ArticleId IdType="pubmed">33162985</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian T.H., Glascow N., Barry A.D.F., Moll T., Harvey C., Klimentidis Y.C., et al. Physical exercise is a risk factor for amyotrophic lateral sclerosis: convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. EBioMedicine. 2021;68 doi: 10.1016/j.ebiom.2021.103397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103397</ArticleId><ArticleId IdType="pmc">PMC8170114</ArticleId><ArticleId IdType="pubmed">34051439</ArticleId></ArticleIdList></Reference><Reference><Citation>Corley J., Cox S.R., Harris S.E., Hernandez M.V., Maniega S.M., Bastin M.E., et al. Epigenetic signatures of smoking associate with cognitive function, brain structure, and mental and physical health outcomes in the Lothian Birth Cohort 1936. Transl Psychiatry. 2019;9:248. doi: 10.1038/s41398-019-0576-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0576-5</ArticleId><ArticleId IdType="pmc">PMC6779733</ArticleId><ArticleId IdType="pubmed">31591380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong D., Liu X., Li J., Ouyang R., Chen P. The role of cigarette smoke-induced epigenetic alterations in inflammation. Epigenetics Chromatin. 2019;12:65. doi: 10.1186/s13072-019-0311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-019-0311-8</ArticleId><ArticleId IdType="pmc">PMC6844059</ArticleId><ArticleId IdType="pubmed">31711545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild C.P. Complementing the genome with an &#x201c;exposome&#x201d;: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14:1847&#x2013;1850. doi: 10.1158/1055-9965.EPI-05-0456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-05-0456</ArticleId><ArticleId IdType="pubmed">16103423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Roos P.M., Piehl F., Kamel F., Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;193. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Horton D.K., Mitsumoto H. Potential environmental factors in amyotrophic lateral sclerosis. Neurol Clin. 2015;33:877&#x2013;888. doi: 10.1016/j.ncl.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.009</ArticleId><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer P.S., Lagrange E., Camu W. ALS and environment: clues from spatial clustering? Rev Neurol (Paris) 2019;175:652&#x2013;663. doi: 10.1016/j.neurol.2019.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.04.007</ArticleId><ArticleId IdType="pubmed">31230725</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor B.J., Singleton A.B. Nature versus nurture: death of a dogma, and the road ahead. Neuron. 2010;68:196&#x2013;200. doi: 10.1016/j.neuron.2010.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.10.002</ArticleId><ArticleId IdType="pmc">PMC2974322</ArticleId><ArticleId IdType="pubmed">20955927</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitsavos C., Makrilakis K., Panagiotakos D.B., Chrysohoou C., Ioannidis I., Dimosthenopoulos C., et al. The J-shape effect of alcohol intake on the risk of developing acute coronary syndromes in diabetic subjects: the CARDIO2000 II study. Diabet Med. 2005;22:243&#x2013;248. doi: 10.1111/j.1464-5491.2004.01384.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2004.01384.x</ArticleId><ArticleId IdType="pubmed">15717869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld J., Swash M. What's in a name? Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases. Neurology. 2006;66:624&#x2013;625. doi: 10.1212/01.wnl.0000205597.62054.db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000205597.62054.db</ArticleId><ArticleId IdType="pubmed">16534097</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzwiecki M.M., Walker D.I., Vermeulen R., Chadeau-Hyam M., Jones D.P., Miller G.W. The exposome: molecules to populations. Annu Rev Pharmacol Toxicol. 2019;59:107&#x2013;127. doi: 10.1146/annurev-pharmtox-010818-021315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010818-021315</ArticleId><ArticleId IdType="pubmed">30095351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild C.P. The exposome: from concept to utility. Int J Epidemiol. 2012;41:24&#x2013;32. doi: 10.1093/ije/dyr236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr236</ArticleId><ArticleId IdType="pubmed">22296988</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S., Visser A.E., D'Ovidio F., Vlaanderen J., Portengen L., Beghi E., et al. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. J Neurol Neurosurg Psychiatry. 2019 doi: 10.1136/jnnp-2019-320986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320986</ArticleId><ArticleId IdType="pubmed">31434759</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., O'Reilly &#xc9;.J., Weisskopf M.G., Logroscino G., McCullough M.L., Thun M.J., et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol. 2011;68:207&#x2013;213. doi: 10.1001/archneurol.2010.367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.367</ArticleId><ArticleId IdType="pmc">PMC3319086</ArticleId><ArticleId IdType="pubmed">21320987</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson L.M., McGuire V., Longstreth W.T., Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151:156&#x2013;163. doi: 10.1093/oxfordjournals.aje.a010183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a010183</ArticleId><ArticleId IdType="pubmed">10645818</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V., Bueno-De-Mesquita H.B., Vermeulen R., Andersen P.M., Kyrozis A., Linseisen J., et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65:378&#x2013;385. doi: 10.1002/ana.21653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21653</ArticleId><ArticleId IdType="pubmed">19399866</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf M.G., McCullough M.L., Calle E.E., Thun M.J., Cudkowicz M., Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160:26&#x2013;33. doi: 10.1093/aje/kwh179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh179</ArticleId><ArticleId IdType="pubmed">15229114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Bellocco R., Hern&#xe1;n M.A., Ye W. Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis&#x2013;a prospective cohort study. Neuroepidemiology. 2006;27:217&#x2013;221. doi: 10.1159/000096956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000096956</ArticleId><ArticleId IdType="pubmed">17106211</ArticleId></ArticleIdList></Reference><Reference><Citation>Opie-Martin S., Jones A., Iacoangeli A., Al-Khleifat A., Oumar M., Shaw P.J., et al. UK case control study of smoking and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:222&#x2013;227. doi: 10.1080/21678421.2019.1706580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1706580</ArticleId><ArticleId IdType="pmc">PMC7261396</ArticleId><ArticleId IdType="pubmed">32301340</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A., Logroscino G., Hern&#xe1;n M.A. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010;81:1249&#x2013;1252. doi: 10.1136/jnnp.2009.180232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.180232</ArticleId><ArticleId IdType="pubmed">20639382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S., Noyce A.J., Hemani G., Nicolas A., Calvo A., Mora G., et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019;85:470&#x2013;481. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y., Fang F. Smoking and amyotrophic lateral sclerosis: a Mendelian randomization study. Ann Neurol. 2019;85:482&#x2013;484. doi: 10.1002/ana.25443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25443</ArticleId><ArticleId IdType="pubmed">30786056</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., Wouters E.F.M. Systemic effects of smoking. Chest. 2007;131:1557&#x2013;1566. doi: 10.1378/chest.06-2179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.06-2179</ArticleId><ArticleId IdType="pubmed">17494805</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf M.G., Ascherio A. Cigarettes and amyotrophic lateral sclerosis: only smoke or also fire? Ann Neurol. 2009;65:361&#x2013;362. doi: 10.1002/ana.21700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21700</ArticleId><ArticleId IdType="pubmed">19399854</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mora G., Moglia C., Manera U., Canosa A., Cammarosano S., et al. Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d'Aosta register. JAMA Neurol. 2017 doi: 10.1001/jamaneurol.2017.1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Wotton C., Talbot K., Goldacre M.J. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry. 2012;83:395&#x2013;398. doi: 10.1136/jnnp-2011-301161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301161</ArticleId><ArticleId IdType="pubmed">22072701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Benzi G., Dossena M., Mutani R., Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472&#x2013;476. doi: 10.1093/brain/awh373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman E.J., Hein M.J., Baron S.L., Gersic C.M. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970&#x2013;1974. doi: 10.1212/WNL.0b013e31826daf50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826daf50</ArticleId><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastos A.F., Orsini M., Machado D., Mello M.P., Nader S., Silva J.G., et al. Amyotrophic lateral sclerosis: one or multiple causes? Neurol Int. 2011;3:e4. doi: 10.4081/ni.2011.e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ni.2011.e4</ArticleId><ArticleId IdType="pmc">PMC3141115</ArticleId><ArticleId IdType="pubmed">21785676</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood C.A., McDermott C.J., Shaw P.J. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10:191&#x2013;204. doi: 10.1080/17482960802549739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802549739</ArticleId><ArticleId IdType="pubmed">19263258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidou B., Couratier P., Besan&#xe7;on C., Nicol M., Preux P.M., Marin B. Epidemiological evidence that physical activity is not a risk factor for ALS. Eur J Epidemiol. 2014;29:459&#x2013;475. doi: 10.1007/s10654-014-9923-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-014-9923-2</ArticleId><ArticleId IdType="pubmed">24986107</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Sports and trauma in amyotrophic lateral sclerosis revisited. J Neurol Sci. 2007;262:45&#x2013;53. doi: 10.1016/j.jns.2007.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.06.021</ArticleId><ArticleId IdType="pubmed">17681549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacorte E., Ferrigno L., Leoncini E., Corbo M., Boccia S., Vanacore N. Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: a systematic review. Neurosci Biobehav Rev. 2016;66:61&#x2013;79. doi: 10.1016/j.neubiorev.2016.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.04.007</ArticleId><ArticleId IdType="pubmed">27108217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.D., Little J., Gomes J., Cashman N.R., Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2016 doi: 10.1016/j.neuro.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman M.H.B., Seelen M., de Jong S.W., Dorresteijn K.R.I.S., van Doormaal P.T.C., van der Kooi A.J., et al. Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:976&#x2013;981. doi: 10.1136/jnnp-2012-304724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304724</ArticleId><ArticleId IdType="pubmed">23418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A., D'Ovidio F., Calvo A., Moglia C., Manera U., Torrieri M.C., et al. Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis. Neuroimage Clin. 2020;27 doi: 10.1016/j.nicl.2020.102312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102312</ArticleId><ArticleId IdType="pmc">PMC7334468</ArticleId><ArticleId IdType="pubmed">32622315</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R. Increased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth? J Neurol Neurosurg Psychiatry. 2013;84:947. doi: 10.1136/jnnp-2013-304935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-304935</ArticleId><ArticleId IdType="pubmed">23447649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Calvo A., Dossena M., Ghiglione P., Mutani R., Mora G. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10:205&#x2013;209. doi: 10.1080/17482960902721634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960902721634</ArticleId><ArticleId IdType="pubmed">19267274</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Leigh P.N. Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis? Brain. 2005;128:451&#x2013;453. doi: 10.1093/brain/awh426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh426</ArticleId><ArticleId IdType="pubmed">15713848</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanacore N. Neurodegenerative causes of death among retired National Football League players. Neurology. 2013;80:1266&#x2013;1267. doi: 10.1212/01.wnl.0000428873.10254.b7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000428873.10254.b7</ArticleId><ArticleId IdType="pubmed">23530154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P., Zhou X. Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study. Hum Mol Genet. 2019;28:688&#x2013;697. doi: 10.1093/hmg/ddy384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy384</ArticleId><ArticleId IdType="pmc">PMC6360326</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J.-.L., Bonnefont-Rousselot D., Bittar R., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaye J.B., Patin F., Piver E., Bruno C., Vasse M., Vourc'h P., et al. Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients. J Neurol Sci. 2017;380:124&#x2013;127. doi: 10.1016/j.jns.2017.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.019</ArticleId><ArticleId IdType="pubmed">28870551</ArticleId></ArticleIdList></Reference><Reference><Citation>Che&#x142;stowska B., Bara&#x144;czyk-Ku&#x17a;ma A., Ku&#x17a;ma-Kozakiewicz M. Dyslipidemia in patients with amyotrophic lateral sclerosis - a case control retrospective study. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:195&#x2013;205. doi: 10.1080/21678421.2020.1832119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1832119</ArticleId><ArticleId IdType="pubmed">33103950</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Ilardi A., Cavallo E., Moglia C., Mutani R., et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2009;73:1681&#x2013;1685. doi: 10.1212/WNL.0b013e3181c1df1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c1df1e</ArticleId><ArticleId IdType="pubmed">19917991</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R., Guo X., Chen X., Zheng Z., Wei Q., Cao B., et al. The serum lipid profiles of amyotrophic lateral sclerosis patients: a study from south-west China and a meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:359&#x2013;365. doi: 10.3109/21678421.2015.1047454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1047454</ArticleId><ArticleId IdType="pubmed">26121273</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Wei Q.Q., Chen Y., Cao B., Ou R., Hou Y., et al. Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:53&#x2013;60. doi: 10.1080/21678421.2018.1550516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550516</ArticleId><ArticleId IdType="pubmed">30784318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja N.A., van der Schouw Y.T., Fischer K., Sizoo E.M., Huisman M.H.B., Veldink J.H., et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:638&#x2013;642. doi: 10.1136/jnnp.2010.236752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.236752</ArticleId><ArticleId IdType="pubmed">21471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Luo X., Chen X., Shang H. Lipid profile in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Neurol. 2020;11 doi: 10.3389/fneur.2020.567753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.567753</ArticleId><ArticleId IdType="pmc">PMC7593382</ArticleId><ArticleId IdType="pubmed">33178110</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer R.M., Mayer B., Kuncl R.W., Check D.P., Cahoon E.K., Rivera D.R., et al. Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs. Amyotroph Lateral Scler Frontotemporal Degener. 2019:1&#x2013;11. doi: 10.1080/21678421.2019.1682613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1682613</ArticleId><ArticleId IdType="pubmed">31684770</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C., Calvo A., Grassano M., Canosa A., Manera U., D'Ovidio F., et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90:666&#x2013;673. doi: 10.1136/jnnp-2018-319611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Deng J., Jaffa M., Cudkowicz M.E., Wills A.-.M. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:20&#x2013;24. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R., D'Ovidio F., Logroscino G., Chi&#xf2; A. The links between diabetes mellitus and amyotrophic lateral sclerosis. Neurol Sci. 2021;42:1377&#x2013;1387. doi: 10.1007/s10072-021-05099-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05099-0</ArticleId><ArticleId IdType="pmc">PMC7955983</ArticleId><ArticleId IdType="pubmed">33544228</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Pradat P.-.F., Ludolph A.C., Loeffler J.-.P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicero C.E., Mostile G., Vasta R., Rapisarda V., Signorelli S.S., Ferrante M., et al. Metals and neurodegenerative diseases. A systematic review. Environ Res. 2017;159:82&#x2013;94. doi: 10.1016/j.envres.2017.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2017.07.048</ArticleId><ArticleId IdType="pubmed">28777965</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T., Hatch E.E., Vinceti M. Residential exposure to electromagnetic fields and risk of amyotrophic lateral sclerosis: a dose-response meta-analysis. Sci Rep. 2021;11:11939. doi: 10.1038/s41598-021-91349-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91349-2</ArticleId><ArticleId IdType="pmc">PMC8185090</ArticleId><ArticleId IdType="pubmed">34099747</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna J., Leleu J.-.P., Preux P.-.M., Corcia P., Couratier P., Marin B., et al. Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: a geo-epidemiological population-based study. Environ Res. 2019;176 doi: 10.1016/j.envres.2019.108525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2019.108525</ArticleId><ArticleId IdType="pubmed">31226626</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ovidio F., d'Errico A., Calvo A., Costa G., Chi&#xf2; A. Occupations and amyotrophic lateral sclerosis: are jobs exposed to the general public at higher risk? Eur J Public Health. 2017;27:643&#x2013;647. doi: 10.1093/eurpub/ckx006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckx006</ArticleId><ArticleId IdType="pubmed">28201634</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ovidio F., d'Errico A., Farina E., Calvo A., Costa G., Chi&#xf2; A. Amyotrophic lateral sclerosis incidence and previous prescriptions of drugs for the nervous system. Neuroepidemiology. 2016;47:59&#x2013;66. doi: 10.1159/000448618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000448618</ArticleId><ArticleId IdType="pubmed">27561959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G., Mash D.C. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler. 2009;10(Suppl 2):7&#x2013;20. doi: 10.3109/17482960903286009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903286009</ArticleId><ArticleId IdType="pubmed">19929726</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwoli L., Baqui A.H., Benfield T., Bosurgi R., Godlee F., Hancocks S., et al. Call for emergency action to limit global temperature increases, restore biodiversity, and protect health: wealthy nations must do much more, much faster. Neurology. 2021 doi: 10.1212/WNL.0000000000012691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012691</ArticleId><ArticleId IdType="pmc">PMC8520385</ArticleId><ArticleId IdType="pubmed">34489321</ArticleId></ArticleIdList></Reference><Reference><Citation>Col&#xf3;n-Gonz&#xe1;lez F.J., Sewe M.O., Tompkins A.M., Sj&#xf6;din H., Casallas A., Rockl&#xf6;v J., et al. Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study. Lancet Planet Health. 2021;5:e404&#x2013;e414. doi: 10.1016/S2542-5196(21)00132-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2542-5196(21)00132-7</ArticleId><ArticleId IdType="pmc">PMC8280459</ArticleId><ArticleId IdType="pubmed">34245711</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamphlett R., Fang F. Season and weather patterns at time of birth in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13(5):459&#x2013;464. doi: 10.3109/17482968.2012.700938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.700938</ArticleId><ArticleId IdType="pubmed">22871076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zammit C., Torzhenskaya N., Ozarkar P.D., Calleja Agius J. Neurological disorders vis-&#xe0;-vis climate change. Early Hum Dev. 2021;155 doi: 10.1016/j.earlhumdev.2020.105217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2020.105217</ArticleId><ArticleId IdType="pubmed">33069514</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino J.G. Climate change. Neurology. 2021;97:657. doi: 10.1212/WNL.0000000000012692. &#x2013;657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012692</ArticleId><ArticleId IdType="pubmed">34489320</ArticleId></ArticleIdList></Reference><Reference><Citation>McMichael C. Human mobility, climate change, and health: unpacking the connections. Lancet Planet Health. 2020;4:e217&#x2013;e218. doi: 10.1016/S2542-5196(20)30125-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2542-5196(20)30125-X</ArticleId><ArticleId IdType="pubmed">32559436</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman K.J. Causes. Am J Epidemiol. 1976;104:587&#x2013;592. doi: 10.1093/oxfordjournals.aje.a112335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a112335</ArticleId><ArticleId IdType="pubmed">998606</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffitt T.E., Caspi A., Rutter M. Measured gene-environment interactions in psychopathology: concepts, research strategies, and implications for research, intervention, and public understanding of genetics. Perspect Psychol Sci. 2006;1:5&#x2013;27. doi: 10.1111/j.1745-6916.2006.00002.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-6916.2006.00002.x</ArticleId><ArticleId IdType="pubmed">26151183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottman R. Gene-environment interaction: definitions and study designs. Prev Med. 1996;25:764&#x2013;770. doi: 10.1006/pmed.1996.0117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/pmed.1996.0117</ArticleId><ArticleId IdType="pmc">PMC2823480</ArticleId><ArticleId IdType="pubmed">8936580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol. 1990;7:177&#x2013;185. doi: 10.1002/gepi.1370070302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.1370070302</ArticleId><ArticleId IdType="pmc">PMC2819318</ArticleId><ArticleId IdType="pubmed">2369997</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman K.J., Greenland S., Walker A.M. Concepts of interaction. Am J Epidemiol. 1980;112:467&#x2013;470. doi: 10.1093/oxfordjournals.aje.a113015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a113015</ArticleId><ArticleId IdType="pubmed">7424895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlbom A., Alfredsson L. Interaction: a word with two meanings creates confusion. Eur J Epidemiol. 2005;20:563&#x2013;564. doi: 10.1007/s10654-005-4410-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-005-4410-4</ArticleId><ArticleId IdType="pubmed">16119427</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemiatycki J., Thomas D.C. Biological models and statistical interactions: an example from multistage carcinogenesis. Int J Epidemiol. 1981;10:383&#x2013;387. doi: 10.1093/ije/10.4.383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/10.4.383</ArticleId><ArticleId IdType="pubmed">7327838</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S. Interactions in epidemiology: relevance, identification, and estimation. Epidemiology. 2009;20:14&#x2013;17. doi: 10.1097/EDE.0b013e318193e7b5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e318193e7b5</ArticleId><ArticleId IdType="pubmed">19234397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman K.J., Lash T.L., Haneuse S., VanderWeele T.J. 4th ed. LWW; 2021. Modern Epidemiology.</Citation></Reference><Reference><Citation>Saracci R. Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction. Int J Cancer. 1977;20:323&#x2013;331. doi: 10.1002/ijc.2910200302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.2910200302</ArticleId><ArticleId IdType="pubmed">903186</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaffe K., Haan M., Byers A., Tangen C., Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology. 2000;54:1949&#x2013;1954. doi: 10.1212/wnl.54.10.1949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.54.10.1949</ArticleId><ArticleId IdType="pubmed">10822435</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Calvo A., Chio A., Colville S., Ellis C.M., Hardiman O., et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13:1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mazzini L., D'Alfonso S., Corrado L., Canosa A., Moglia C., et al. The multistep hypothesis of ALS revisited: the role of genetic mutations. Neurology. 2018;91:e635&#x2013;e642. doi: 10.1212/WNL.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Knol M.J., van der Tweel I., Grobbee D.E., Numans M.E., Geerlings M.I. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36:1111&#x2013;1118. doi: 10.1093/ije/dym157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dym157</ArticleId><ArticleId IdType="pubmed">17726040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordovas J.M., Corella D., Demissie S., Cupples L.A., Couture P., Coltell O., et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham study. Circulation. 2002;106:2315&#x2013;2321. doi: 10.1161/01.cir.0000036597.52291.c9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000036597.52291.c9</ArticleId><ArticleId IdType="pubmed">12403660</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386&#x2013;389. doi: 10.1126/science.1083968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083968</ArticleId><ArticleId IdType="pubmed">12869766</ArticleId></ArticleIdList></Reference><Reference><Citation>van Os J., Rutten B.P., Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull. 2008;34:1066&#x2013;1082. doi: 10.1093/schbul/sbn117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbn117</ArticleId><ArticleId IdType="pmc">PMC2632485</ArticleId><ArticleId IdType="pubmed">18791076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodato M.A., Woodworth M.B., Lee S., Evrony G.D., Mehta B.K., Karger A., et al. Somatic mutation in single human neurons tracks developmental and transcriptional history. Science. 2015;350:94&#x2013;98. doi: 10.1126/science.aab1785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab1785</ArticleId><ArticleId IdType="pmc">PMC4664477</ArticleId><ArticleId IdType="pubmed">26430121</ArticleId></ArticleIdList></Reference><Reference><Citation>Karg K., Sen S. Gene&#xa0;&#xd7;&#xa0;environment interaction models in psychiatric genetics. Curr Top Behav Neurosci. 2012;12:441&#x2013;462. doi: 10.1007/7854_2011_184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/7854_2011_184</ArticleId><ArticleId IdType="pmc">PMC4058325</ArticleId><ArticleId IdType="pubmed">22241248</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Kirby J., Highley R., Shaw P.J. The spectrum of C9orf72-mediated neurodegeneration and amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12:326&#x2013;339. doi: 10.1007/s13311-015-0342-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0342-1</ArticleId><ArticleId IdType="pmc">PMC4404438</ArticleId><ArticleId IdType="pubmed">25731823</ArticleId></ArticleIdList></Reference><Reference><Citation>Morahan J.M., Yu B., Trent R.J., Pamphlett R. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology. 2007;28:532&#x2013;540. doi: 10.1016/j.neuro.2006.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2006.11.007</ArticleId><ArticleId IdType="pubmed">17204329</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra F.P., Beleza-Meireles A., Leigh N.P., Shaw C.E., Al-Chalabi A. Interaction between PON1 and population density in amyotrophic lateral sclerosis. Neuroreport. 2009;20:186&#x2013;190. doi: 10.1097/WNR.0b013e32831af220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0b013e32831af220</ArticleId><ArticleId IdType="pubmed">19104460</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr G. Special report: the human genome: biology 2.0. Economist. 2010;395:50.</Citation></Reference><Reference><Citation>Vasta R., Calvo A., Moglia C., Cammarosano S., Manera U., Canosa A., et al. Spatial epidemiology of amyotrophic lateral sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis. Eur J Neurol. 2018 doi: 10.1111/ene.13586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13586</ArticleId><ArticleId IdType="pubmed">29377594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tammen S.A., Friso S., Choi S.W. Epigenetics: the link between nature and nurture. Mol Aspects Med. 2013;34:753&#x2013;764. doi: 10.1016/j.mam.2012.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2012.07.018</ArticleId><ArticleId IdType="pmc">PMC3515707</ArticleId><ArticleId IdType="pubmed">22906839</ArticleId></ArticleIdList></Reference><Reference><Citation>Blechter B., Wong J.Y.Y., Agnes Hsiung C., Hosgood H.D., Yin Z., Shu X.O., et al. Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia. Environ Int. 2021;147 doi: 10.1016/j.envint.2020.105975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2020.105975</ArticleId><ArticleId IdType="pmc">PMC8378844</ArticleId><ArticleId IdType="pubmed">33385923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G., Andrew A.S., Traynor B.J., Chi&#xf2; A., Butt T.H., Stommel E.W. Gene-environment-time interactions in neurodegenerative diseases: hypotheses and research approaches. Ann Neurosci. 2018;25:261&#x2013;267. doi: 10.1159/000495321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495321</ArticleId><ArticleId IdType="pmc">PMC6470336</ArticleId><ArticleId IdType="pubmed">31000966</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya V.A., Patani R. Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective. Brain. 2020;143:1057&#x2013;1072. doi: 10.1093/brain/awz360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz360</ArticleId><ArticleId IdType="pmc">PMC7174045</ArticleId><ArticleId IdType="pubmed">31851317</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas D. Gene&#x2013;environment-wide association studies: emerging approaches. Nat Rev Genet. 2010;11:259&#x2013;272. doi: 10.1038/nrg2764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2764</ArticleId><ArticleId IdType="pmc">PMC2891422</ArticleId><ArticleId IdType="pubmed">20212493</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerman KE, Pham DT, Hong L, Chen Y, Sevilla-Gonz&#xe1;lez M, Sung YJ, et&#xa0;al. GEM: scalable and flexible gene-environment interaction analysis in millions of samples. 2020. 10.1101/2020.05.13.090803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545347</ArticleId><ArticleId IdType="pubmed">34695175</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele J.C., McGeer P.L. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2008;70:1984&#x2013;1990. doi: 10.1212/01.wnl.0000312571.81091.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000312571.81091.26</ArticleId><ArticleId IdType="pubmed">18490618</ArticleId></ArticleIdList></Reference><Reference><Citation>Upstill-Goddard R., Eccles D., Fliege J., Collins A. Machine learning approaches for the discovery of gene-gene interactions in disease data. Brief Bioinform. 2013;14:251&#x2013;260. doi: 10.1093/bib/bbs024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbs024</ArticleId><ArticleId IdType="pubmed">22611119</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo C.L., Liew M.J., Mohamad M.S., Salleh A.H.M. A review for detecting gene-gene interactions using machine learning methods in genetic epidemiology. Biomed Res Int. 2013;2013 doi: 10.1155/2013/432375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/432375</ArticleId><ArticleId IdType="pmc">PMC3818807</ArticleId><ArticleId IdType="pubmed">24228248</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q., Li D., Huang X., Ren B., Yue L., Du B., et al. Identifying gene-environment interactions on the efficacy of folic acid therapy for hyperhomocysteinemia based on prediction model. Nutr Res. 2020;77:54&#x2013;61. doi: 10.1016/j.nutres.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2020.03.001</ArticleId><ArticleId IdType="pubmed">32320840</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>